Latest filing published 07 Apr 2011 for INMEDICA DEVELOPMENT CORP, €18k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
David P. Martin: trading record in brief
David P. Martin discloses dealings in Inmedica Development Corp to SEC (Form 4). In total, 5 filings cover trades dated from 15 June 2009 to 17 February 2011.
Purchases make up the whole of the open-market record (4 purchases, €42k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2011, the count stands at 3 purchases and no sales.
In size, the median ticket on the buying side is €11k.
Most recently, on 7 April 2011, the filings show an open-market purchase worth €18k in Inmedica Development Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David P. Martin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 330,000 shares@ US$0.075Common StockSEC:0001076542-11-000035:0Canonical exit: 13 Sept 2009 (T+90)
- 175,500 shares0Common StockSEC:0001076542-11-000036:0
- 2,000,000 shares@ US$0.0075Common StockSEC:0001076542-11-000036:1Canonical exit: 11 Nov 2010 (T+90)
- 200,000 shares@ US$0.075Common StockSEC:0001076542-11-000036:2Canonical exit: 18 May 2011 (T+90)
- 330,000 shares@ US$0.0075COMMON STOCKSEC:0001076542-10-000015:0Canonical exit: 13 Sept 2009 (T+90)
5 of 5 declarations